Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3

Y Miyoshi, K Iwao, Y Nagasawa, T Aihara, Y Sasaki… - Cancer research, 1998 - AACR
Y Miyoshi, K Iwao, Y Nagasawa, T Aihara, Y Sasaki, S Imaoka, M Murata, T Shimano…
Cancer research, 1998AACR
We screened 75 primary hepatocellular carcinomas for somatic mutations in the entire
coding region of the β-catenin gene. We detected somatic mutations in 14 tumors; 12 were
considered to cause amino acid substitutions and 2 were interstitial deletions of 51 or 195
nucleotides of genomic DNA, corresponding to exon 3. Among the 12 point mutations, 6
occurred at potential serine/threonine phosphorylation residues of codons 33, 41, or 45. The
remaining six tumors contained a mutation at codon 32 (aspartic acid) or 34 (glycine) …
Abstract
We screened 75 primary hepatocellular carcinomas for somatic mutations in the entire coding region of the β-catenin gene. We detected somatic mutations in 14 tumors; 12 were considered to cause amino acid substitutions and 2 were interstitial deletions of 51 or 195 nucleotides of genomic DNA, corresponding to exon 3. Among the 12 point mutations, 6 occurred at potential serine/threonine phosphorylation residues of codons 33, 41, or 45. The remaining six tumors contained a mutation at codon 32 (aspartic acid) or 34 (glycine), flanking to the serine residue at codon 33. By Western blot analysis, we confirmed accumulation of β-catenin in five tumors for which frozen tissues were available; the five included tumors in which amino acid alterations had occurred at codons 32, 34, or 45, and one with a 17-amino acid deletion. Our results suggested that accumulation of β-catenin due to amino acid substitutions at potential serine/threonine phosphorylation residues or at their neighboring codons or interstitial deletions involving exon 3 could contribute to hepatocellular carcinogenesis.
AACR